SYK · Earnings call · 2026Q3T · Full report
Vascular Share Recovery
STRYKER CORP · 2026-10-29 · Importance 26 · Surprise 24
Management characterized any share losses during the interim disruption in the Vascular business as temporary and believes it can win that business back. It expects to return to an offensive commercial posture. The planned AVS launch sometime next year is expected to help diversify the portfolio and support a stronger competitive position in 2027.
Key facts
- Stryker believes any vascular share lost during the interim disruption is temporary and expects to win that business back.